Page last updated: 2024-10-28

hypericin and Candidiasis, Genital

hypericin has been researched along with Candidiasis, Genital in 2 studies

Research Excerpts

ExcerptRelevanceReference
" HYP-LCPS induced a significant reduction in the number of CFU/ml in the mice; thus this formulation indicated it is as effective as a commercial dosage form."1.62In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis. ( Araújo, VHS; Bauab, TM; Calixto, GMF; Chorilli, M; de Araújo, PR; Oshiro-Junior, JA; Rodero, CF; Sato, MR, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Sato, MR2
Oshiro-Junior, JA2
Rodero, CF2
Boni, FI1
Araújo, VHS2
Bauab, TM2
Nicholas, D1
Callan, JF1
Chorilli, M2
de Araújo, PR1
Calixto, GMF1

Other Studies

2 other studies available for hypericin and Candidiasis, Genital

ArticleYear
Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:4

    Topics: Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Li

2022
In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis.
    Medical mycology, 2021, Jul-14, Volume: 59, Issue:8

    Topics: Adhesives; Animals; Anthracenes; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chr

2021